505 High-dimensional analyses of intratumoral myeloid cells highlights presence of distinct myeloid cell phenotypes in immune checkpoint-sensitive and resistant tumors

Abstract

BackgroundImmune checkpoint therapy (ICT) has revolutionized cancer treatment, however, has produced around 20% durable clinical response rates. 1 Multiple studies demonstrate myeloid cell abundance and function in the tumor microenvironment...